|
PARIS, FRANCE / ACCESSWIRE / September 12, 2023 / Ad Scientiam, a global leader in digital biomarkers, has announced a partnership with Sanofi to launch MSDETECT, an international, multicenter, longitudinal study. MSDETECT aims to evaluate the ability of MSCopilot®, a medical software device, to detect early signs of disability worsening in people with multiple sclerosis PwMS. The study will... Lire le communiqué |
